TTK Healthcare Limited (BOM:507747)
India · Delayed Price · Currency is INR 921.35
+1.35 (0.15%)
At close: Jul 6, 2026
TTK Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8,573 | 8,015 | 7,528 | 7,251 | 5,992 | |
Revenue Growth (YoY) | 6.96% | 6.47% | 3.82% | 21.00% | 25.87% |
Cost of Revenue | 4,249 | 3,965 | 3,560 | 3,630 | 2,912 |
Gross Profit | 4,324 | 4,050 | 3,968 | 3,621 | 3,080 |
Selling, General & Admin | 2,803 | 2,582 | 2,488 | 2,268 | 1,952 |
Other Operating Expenses | 1,255 | 1,174 | 1,100 | 1,034 | 907.86 |
Operating Expenses | 4,149 | 3,843 | 3,724 | 3,435 | 2,988 |
Operating Income | 174.24 | 206.63 | 244.22 | 186.81 | 92.82 |
Interest Expense | -17.67 | -19.49 | -19.29 | -52.39 | -32.38 |
Interest & Investment Income | 693.5 | 695.15 | 622.17 | 463.7 | 147.59 |
Currency Exchange Gain (Loss) | 10.92 | 2.11 | 2.57 | 5.62 | 3.12 |
Other Non Operating Income (Expenses) | 5.45 | 1.54 | -6.94 | 14 | 12.6 |
EBT Excluding Unusual Items | 866.45 | 885.93 | 842.73 | 617.74 | 223.75 |
Gain (Loss) on Sale of Assets | -0.07 | -0.31 | -0.33 | -1.38 | -0.16 |
Asset Writedown | - | -0.01 | -1.2 | - | -0.13 |
Other Unusual Items | -40.75 | 197.71 | - | - | 24.91 |
Pretax Income | 825.63 | 1,083 | 841.2 | 616.36 | 248.37 |
Income Tax Expense | 168.83 | 266.75 | 212.78 | 169.68 | 63.27 |
Earnings From Continuing Operations | 656.81 | 816.57 | 628.42 | 446.68 | 185.1 |
Earnings From Discontinued Operations | - | - | - | 5,950 | 230.78 |
Net Income | 656.81 | 816.57 | 628.42 | 6,397 | 415.88 |
Net Income to Common | 656.81 | 816.57 | 628.42 | 6,397 | 415.88 |
Net Income Growth | -19.56% | 29.94% | -90.18% | 1438.20% | -10.45% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 |
EPS (Basic) | 46.48 | 57.79 | 44.47 | 452.73 | 29.43 |
EPS (Diluted) | 46.48 | 57.79 | 44.47 | 452.73 | 29.43 |
EPS Growth | -19.57% | 29.95% | -90.18% | 1438.20% | -10.45% |
Free Cash Flow | -269.51 | -168.16 | -153.27 | -365.1 | 394.91 |
Free Cash Flow Per Share | -19.07 | -11.90 | -10.85 | -25.84 | 27.95 |
Dividend Per Share | 10.000 | 10.000 | 10.000 | 10.000 | 10.000 |
Dividend Growth | - | - | - | - | 66.67% |
Gross Margin | 50.43% | 50.53% | 52.71% | 49.94% | 51.40% |
Operating Margin | 2.03% | 2.58% | 3.24% | 2.58% | 1.55% |
Profit Margin | 7.66% | 10.19% | 8.35% | 88.22% | 6.94% |
Free Cash Flow Margin | -3.14% | -2.10% | -2.04% | -5.04% | 6.59% |
EBITDA | 254.51 | 283.09 | 367.16 | 314.38 | 217.99 |
EBITDA Margin | 2.97% | 3.53% | 4.88% | 4.34% | 3.64% |
D&A For EBITDA | 80.28 | 76.47 | 122.95 | 127.57 | 125.16 |
EBIT | 174.24 | 206.63 | 244.22 | 186.81 | 92.82 |
EBIT Margin | 2.03% | 2.58% | 3.24% | 2.58% | 1.55% |
Effective Tax Rate | 20.45% | 24.62% | 25.30% | 27.53% | 25.47% |
Revenue as Reported | 9,294 | 8,727 | 8,154 | 7,734 | 6,156 |
Advertising Expenses | 1,125 | 1,048 | 1,132 | 1,012 | 893.1 |